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Abstract: The purpose of this study was to characterize the cell surface proteome of native 
compared to cultured equine retinal pigment epithelium (RPE) cells. The RPE plays an 
essential role in visual function and represents the outer blood-retinal barrier. We are 
investigating immunopathomechanisms of equine recurrent uveitis, an autoimmune 
inflammatory disease in horses leading to breakdown of the outer blood-retinal barrier and 
influx of autoreactive T-cells into affected horses’ vitrei. Cell surface proteins of native and 
cultured RPE cells from eye-healthy horses were captured by biotinylation, analyzed  
by high resolution mass spectrometry coupled to liquid chromatography (LC MS/MS),  
and the most interesting candidates were validated by PCR, immunoblotting and 
immunocytochemistry. A total of 112 proteins were identified, of which 84% were cell 
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surface membrane proteins. Twenty-three of these proteins were concurrently expressed by 
both cell states, 28 proteins exclusively by native RPE cells. Among the latter were two 
RPE markers with highly specialized RPE functions: cellular retinaldehyde-binding protein 
(CRALBP) and retinal pigment epithelium-specific protein 65kDa (RPE65). Furthermore, 
61 proteins were only expressed by cultured RPE cells and absent in native cells. As we 
believe that initiating events, leading to the breakdown of the outer blood-retinal barrier, 
take place at the cell surface of RPE cells as a particularly exposed barrier structure, this 
differential characterization of cell surface proteomes of native and cultured equine RPE 
cells is a prerequisite for future studies. 
Keywords: equine recurrent uveitis; membrane protein; outer blood-retinal barrier;  
retinal pigment epithelium cells; cell line; proteomics 
 
1. Introduction 
Protein expression analysis with mass spectrometry has become an important tool to understand 
participating proteins in physiological networks and on cellular levels [1]. The proteome is the set of 
expressed proteins in a given type of cell at a given time under defined conditions [2]. Analysis 
technologies continually improved in the field of proteomics in the last years, especially regarding 
sensitivity of mass spectrometric analysis [3]. This enables increasingly better investigations of 
complex and widely dynamic protein concentrations [3]. Two-dimensional polyacrylamide gel 
electrophoresis (2D-PAGE) allowed resolution of thousands of proteins [4], but it also has major 
disadvantages, mainly inadequate resolution of cell surface membrane proteins. Recently, several 
different approaches were applied to enhance cell surface membrane protein identification in tissues 
through variations in sample preparation [5,6]. Further, mass spectrometry is rapidly advancing, and 
liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS) has emerged as a highly 
precise and sensitive high-throughput technique for protein identification and characterization and 
facilitates discovery of proteins [3,6]. 
We are interested in immunopathomechanisms of equine recurrent uveitis (ERU), a spontaneous, 
organ-specific autoimmune disease characterized through remitting-relapsing attacks of leukocytes to 
the retina [1]. Earlier examinations of immune and target tissue proteomes revealed several interesting 
findings in this model disease for human autoimmune uveitis, e.g., identification of a novel 
autoantigen with importance for ERU and correspondent human disease [7,8]. Another surprising 
finding was the involvement of regulated granulocytes in intraocular inflammation of this T-cell 
mediated disease [4]. Moreover, differential proteome analyses of changes in targeted retina revealed a 
decisive role for retinal Mueller glial cells in pathogenesis [1,9,10]. A key event of uveitis is migration 
of immune cells through the blood-retinal barrier, because the inner eye is physiologically devoid of 
leukocytes. There are two different structures of blood-retinal barriers in the eye. Inner blood-retinal 
barrier is formed by two beds of capillary endothelia [11]. Outer blood-retinal barrier lies on the outer 
surface of the photoreceptor layer and closely resembles the ventricular portion of the blood-brain 
barrier [11]. Horses possess a widely avascular retina [12], and activated cells pass outer blood-retinal 
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barrier in ERU [13]. Outer blood-retinal barrier is formed and maintained by retinal pigment 
epithelium (RPE) cells [11]. RPE cells use different mechanisms to establish important barrier 
function, including membrane pumps, transporters and different channels [11]. Initiating events of 
blood-retinal barrier breakdown are expected to take place at the cell surface as a particularly exposed 
barrier structure. So far, there is only very limited knowledge about the cell surface membrane 
proteome of retinal pigment epithelium cells, and therefore, the goal of this study was the identification 
of physiological RPE cell surface protein expression. Since studies for RPE cell functions are mainly 
performed with RPE cell lines [14], we additionally examined changes in RPE cell surface protein 
expression induced through cultivation of cells to evaluate modifications of RPE cells after passaging. 
2. Results 
2.1. Cell Surface Protein Expression of Physiological RPE Cells 
A total of 112 proteins were identified with two or more peptides on the cell surfaces of RPE cells 
derived from healthy eyes (Table 1). Of these identified proteins, 84% were membrane proteins 
according to GO terminology (Table 1, cellular localization and Figure 1). Major differences were seen 
in proteins with GO for transport dominated in native cells (Figure 1A, bright blue segment) whereas 
proteins assigned with cell adhesion (Figure 1, dark green) and cell communication (Figure 1, grey) 
were upregulated in P4 cells (Figure 1B) in comparison to native RPE cells (Figure 1A). The relation 
between the last two GO terms, cell adhesion and cell communication, to all GO for biological process 
remained the same (Figure 1A,B, dark green and grey segments). In detail, 23 proteins were equally 
detectable in both examined states, native and passage-4 cells (20.5% of all 112 identified proteins), 
(Table 1, proteins 1–23). Beta-actin was among these unchanged proteins under both conditions, as 
seen in PCR and Western blot analysis, indicating equal protein loading for mass spectrometry  
(Table 1, protein 3; Figures 2 and 3). Besides some keratins (Table 1; proteins 7–12), an integrin  
(Table 1; protein 4) and six ion channel proteins (Table 1; proteins 15–17, 21–23) were stably 
expressed in native and cultured RPE cells. 
Table 1. Cell surface proteins expressed by RPE cells of horses. Proteins listed were 
identified by LC MS/MS with a probability score that is significant with p < 0.05 if the 
confidence score was >30 at a significance threshold for the Mascot result of p ≤ 0.01.  
N = native RPE cells; P4 = passage-4 RPE cells; C = cytoplasmatic; M = membrane 
associated; E = extracellular. 
# Identified protein Accession number MW (kDa) 
Occurrence 
Unique 
peptide count 
Sequence 
coverage (%) 
Cellular 
localization 
N P4 N P4 N P4 C M E 
1 
ATP-binding cassette,  
sub-family C, member 1 
ENSECAP00000005390 164 x x 9 17 9 17  x  
2 Basigin ENSECAP00000010130 24 x x 4 3 28 28  x  
3 Beta-actin ENSECAP00000013637 41 x x 2 3 8 23 x   
4 CD29 ENSECAP00000020201 88 x x 6 21 11 34  x  
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Table 1. Cont. 
# Identified protein Accession number 
MW 
(kDa) 
Occurrence 
Unique 
peptide 
count 
Sequence 
coverage 
(%) 
Cellular 
localization 
N P4 N P4 N P4 C M E 
5 CD44 ENSECAP00000008636 77 x x 2 7 4 14 x x  
6 CD90 ENSECAP00000007841 18 x x 3 4 24 30  x  
7 Cytokeratin 1 ENSECAP00000019935 66 x x 3 3 6 7 x x  
8 Cytokeratin 2 ENSECAP00000015380 61 x x 3 3 9 9 x   
9 Cytokeratin 16 ENSECAP00000004544 51 x x 6 4 19 13 x   
10 Cytokeratin 10 ENSECAP00000018005 43 x x 14 14 28 30 x   
11 Cytokeratin 5 ENSECAP00000018010 62 x x 11 8 17 14 x x  
12 Cytokeratin 6C ENSECAP00000011363 60 x x 2 3 12 13 x   
13 Desmoplakin ENSECAP00000012688 168 x x 4 4 4 5  x  
14 
Ectonucleotide pyrophosphatase/ 
phosphodiesterase 1 
ENSECAP00000011146 96 x x 5 15 10 28  x x 
15 Na(+)/K(+) ATPase alpha-1 subunit ENSECAP00000022397 113 x x 2 3 13 12  x  
16 Na(+)/K(+) ATPase alpha-3 subunit ENSECAP00000022127 113 x x 10 5 15 8  x  
17 Na(+)/K(+) ATPase beta-1 subunit ENSECAP00000015566 35 x x 3 3 14 14  x  
18 Neuroplastin ENSECAP00000006428 42 x x 2 5 6 16  x  
19 Plexin B2 ENSECAP00000017324 183 x x 3 10 3 11 x x  
20 Pyruvate Carboxylase ENSECAP00000022492 130 x x 5 13 7 18  x  
21 Solute carrier family 2, member 1 ENSECAP00000000404 54 x x 7 5 12 9 x x  
22 Solute carrier family 3, member 2 ENSECAP00000007939 62 x x 10 10 28 30 x x  
23 Solute carrier family 44, member 2 ENSECAP00000009162 79 x x 2 3 3 8  x  
24 Carbonic anhydrase 14 ENSECAP00000002354 31 x  4 0 25 0  x  
25 CD107a ENSECAP00000015399 44 x  2 1 8 4  x  
26 CD107b ENSECAP00000016219 46 x  2 1 5 2  x  
27 CD156c ENSECAP00000006414 82 x  2 0 6 0 x x  
28 CD36L2 ENSECAP00000022283 50 x  2 0 7 0  x  
29 Cellular retinaldehyde-binding protein ENSECAP00000002273 36 x  3 0 12 0 x   
30 Chondroitin sulfate proteoglycan 5 ENSECAP00000020923 54 x  2 0 9 0  x  
31 Cytokeratin 17 ENSECAP00000014186 48 x  3 1 14 7 x x  
32 Cytokeratin 75 ENSECAP00000008235 59 x  2 0 12 7 x   
33 Cytokeratin 77 ENSECAP00000006788 63 x  2 1 8 5 x   
34 Glycoprotein M6A ENSECAP00000014508 31 x  5 0 18 0  x  
35 
Heat shock protein 90 kDa beta 
member 1 
ENSECAP00000009012 92 x  2 1 4 2 x x  
36 Inward rectifier K(+) channel Kir7.1 ENSECAP00000005853 41 x  3 0 9 0  x  
37 Retinol dehydrogenase 5 ENSECAP00000017236 35 x  3 0 15 0  x  
38 RPE65 ENSECAP00000008347 60 x  3 0 11 0  x  
39 Solute carrier family 1, member 4 ENSECAP00000009506 55 x  3 1 8 4 x x  
40 Solute carrier family 12, member 2 ENSECAP00000013091 119 x  4 1 5 2 x x  
41 Solute carrier family 13, member 3 ENSECAP00000008631 63 x  3 0 7 0  x  
42 Solute carrier family 16, member 1 ENSECAP00000019149 54 x  3 0 7 0  x  
43 Solute carrier family 4, member 7 ENSECAP00000004107 137 x  2 0 3 0  x  
44 Solute carrier family 6, member 13 ENSECAP00000012525 68 x  4 0 9 0  x  
45 Solute carrier family 6, member 9 ENSECAP00000003659 71 x  3 0 7 0  x  
46 Solute carrier family 6, member 6 ENSECAP00000011341 70 x  2 0 5 0  x  
47 Solute carrier family 6, member 20 ENSECAP00000018972 66 x  3 0 7 0  x  
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Table 1. Cont. 
# Identified protein Accession number 
MW 
(kDa) 
Occurrence 
Unique 
peptide 
count 
Sequence 
coverage 
(%) 
Cellular 
localization 
N P4 N P4 N P4 C M E 
48 
Solute carrier organic anion 
transporter family, member 1A2 
ENSECAP00000015472 74 x  2 0 3 0  x  
49 
Solute carrier organic anion 
transporter family, member 1B3 
ENSECAP00000010749 76 x  4 0 9 0  x  
50 Thioredoxin domain containing 5 ENSECAP00000000114 36 x  2 0 12 0 x   
51 Transmembrane protein 27 ENSECAP00000017054 25 x  3 0 18 0  x  
52 Actin, alpha 1 ENSECAP00000000126 42  x 0 5 0 18 x   
53 Adlican ENSECAP00000015067 313  x 0 5 0 3   x 
54 Anoctamin 6 ENSECAP00000010736 105  x 0 3 0 7  x  
55 Cadherin 13 ENSECAP00000018588 76  x 0 7 0 15  x  
56 Cadherin 2 ENSECAP00000008264 91  x 0 8 0 21  x  
57 
Calcium channel, voltage-dependent, 
alpha 2/delta subunit 1 
ENSECAP00000008740 104  x 0 5 0 8  x  
58 Catenin, gamma ENSECAP00000018374 82  x 1 2 2 3 x x  
59 CD105 ENSECAP00000018048 70  x 0 4 0 11  x x 
60 CD109 ENSECAP00000020689 159  x 0 7 0 9   x 
61 CD13 ENSECAP00000007954 110  x 0 2 0 3  x  
62 CD140b ENSECAP00000022400 121  x 1 11 2 17  x  
63 CD142 ENSECAP00000020955 32  x 1 2 6 10  x x 
64 CD280 ENSECAP00000010799 162  x 0 9 0 9  x  
65 CD315 ENSECAP00000014826 98  x 1 3 2 5  x  
66 CD318 ENSECAP00000022716 93  x 1 2 2 4  x  
67 CD362 ENSECAP00000006433 22  x 0 2 0 12  x  
68 CD46 ENSECAP00000007802 32  x 0 2 0 10  x  
69 CD49a ENSECAP00000015387 129  x 0 9 0 13  x  
70 CD49c ENSECAP00000013928 119  x 1 9 1 12  x  
71 CD49d ENSECAP00000009001 114  x 0 5 0 7  x  
72 CD49e ENSECAP00000022617 115  x 0 7 0 11  x  
73 CD51 ENSECAP00000020829 113  x 0 15 0 21  x  
74 CD54 ENSECAP00000011996 57  x 0 2 0 0  x x 
75 CD56 ENSECAP00000017648 93  x 0 3 0 6  x  
76 CD61 ENSECAP00000016485 84  x 0 3 0 8  x  
77 CD71 ENSECAP00000021947 86  x 0 2 0 4  x x 
78 CD73 ENSECAP00000007576 51  x 0 8 0 28 x x  
79 CD91 ENSECAP00000010929 504  x 0 44 0 16  x  
80 Cell adhesion molecule 1 ENSECAP00000013033 47  x 0 2 0 12  x  
81 Dystroglycan 1 ENSECAP00000007588 97  x 0 3 0 6 x x  
82 Endothelin converting enzyme 1 ENSECAP00000014392 86  x 0 2 0 5 x x  
83 EPH receptor A2 ENSECAP00000006952 108  x 0 4 0 5  x  
84 Fibroblast activation protein, alpha ENSECAP00000010111 88  x 0 4 0 8  x  
85 Fibronectin 1 ENSECAP00000005228 262  x 0 35 0 26  x x 
86 Fibulin 1 ENSECAP00000016104 75  x 0 6 0 16  x X 
87 Fibulin 2 ENSECAP00000007213 125  x 1 17 3 24   x 
88 Folate hydrolase 1 ENSECAP00000020544 85  x 0 2 0 5 x x  
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Table 1. Cont. 
# Identified protein Accession number 
MW 
(kDa) 
Occurrence 
Unique 
peptide 
count 
Sequence 
coverage 
(%) 
Cellular 
localization 
N P4 N P4 N P4 C M E 
89 Frizzled family receptor 1 ENSECAP00000000907 60  x 0 2 0 4  x  
90 Frizzled family receptor 2 ENSECAP00000015209 61  x 0 2 0 4 x x  
91 
Immunoglobulin superfamily 
containing leucine-rich repeat 
ENSECAP00000002466 46  x 0 3 0 11   x 
92 
Integrin alpha FG-GAP repeat 
containing 3 
ENSECAP00000022543 60  x 0 5 0 14  x  
93 Integrin, alpha 11 ENSECAP00000020852 133  x 0 7 0 12  x  
94 Integrin, alpha 8 ENSECAP00000011756 117  x 0 8 0 16  x  
95 Integrin, beta 5 ENSECAP00000006461 85  x 1 11 3 22  x  
96 
Latent transforming growth factor beta 
binding protein 2 
ENSECAP00000016809 196  x 0 2 0 2   x 
97 MHC I ENSECAP00000008517 40  x 0 2 0 7  x  
98 Na, K-ATPase beta-3 polypeptide ENSECAP00000017575 27  x 0 2 0 15 x x  
99 Natriuretic peptide receptor C ENSECAP00000017782 60  x 0 4 0 12  x  
100 Neuropilin 1 ENSECAP00000018748 103  x 0 8 0 15 x x  
101 Neuropilin 2 ENSECAP00000015439 105  x 0 2 0 4  x  
102 NOTCH2 ENSECAP00000013532 245  x 0 2 0 2  x  
103 Plexin domain containing 2 ENSECAP00000015262 44  x 0 4 0 13  x  
104 
Propionyl CoA carboxylase,  
alpha polypeptide 
ENSECAP00000016512 56  x 0 4 0 13 x   
105 Protein tyrosine kinase 7 ENSECAP00000009553 98  x 0 11 0 21  x  
106 Solute carrier family 1, member 5 ENSECAP00000009592 56  x 0 3 0 6  x  
107 Sushi domain containing 5 ENSECAP00000005951 67  x 0 4 0 11  x  
108 Thrombospondin 1 ENSECAP00000007423 130  x 0 27 0 37  x x 
109 Transmembrane protein 2 ENSECAP00000019147 154  x 0 3 0 3  x  
110 Tubulin, alpha 1c ENSECAP00000007419 50  x 0 2 0 7 x   
111 Vasorin ENSECAP00000002864 72  x 0 3 0 5  x  
112 Versican ENSECAP00000017347 94  x 0 2 0 4   x 
Figure 1. Classification of RPE cell surface proteins based on GO for biological process of 
native RPE cell proteins (A) and passage-4 RPE cell proteins (B). Numbers in percentages 
(%) correspond to the number of GO terms assigned for respective preparation. GO terms 
defined as others include those with an occurrence of <1.1%. 
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Figure 1. Cont. 
 
2.2. Cell Surface Proteomes of Native and Cultured RPE Cells Differ Considerably 
Interestingly, 28 proteins were only expressed in native RPE cells (25% of all 112 identified 
proteins), (Table 1; proteins 24–51) and they were not detectable in cultured RPE cells (Table 1). 
Among these were cellular retinaldehyde-binding protein (CRALBP) (Table 1, protein 29), retinol 
dehydrogenase 5 (RDH5) (Table 1, protein 37) and retinal pigment epithelium-specific protein 65 kDa 
(RPE65) (Table 1, protein 38), all proteins known to be expressed in RPE cells [15,16]. RPE65 is a 
RPE cell specific protein, which is only expressed in original RPE cells [17]. In contrast, 61 proteins 
were exclusively expressed in RPE cells of passage-4 (54.5% of all 112 identified proteins), for 
example CD49c, fibronectin and thrombospondin 1 (Table 1, proteins 70, 85 and 108). We picked 
CRALBP, RPE65, fibronectin and CD49c and validated these differentially regulated proteins on 
transcriptomic level by PCR (Figure 2), on protein level by Western blot (Figure 3) and by  
immunocytochemistry (Figure 4). According to the results from LC MS/MS, CRALBP and RPE65 
were expressed in native RPE cells but not in passage-4 cells (Figures 2–4). 
Figure 2. Gel electrophoresis of PCR products of native (N) and passage-4 (P4) equine 
RPE cell cDNA on a 2% agarose gel. Beta-actin is equally expressed by both cell states. 
Native RPE cells express CRALBP and RPE65, whereas no signal could be detected in 
passage-4 RPE. Fibronectin and CD49c are expressed distinctly by passage-4 RPE cells, 
while only a faint signal can be seen in native cells. 
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Figure 3. Western blot of a 10% 1D SDS-gel with lysates from native and cultured equine 
RPE passage-4 cells. N = native; P4 = passage-4. 5 µg protein of each lysate were loaded 
per lane. Boxes indicate the expected region for a signal regarding the molecular size of the 
respective protein. 
 
Figure 4. Immunocytochemistry of equine RPE cells. Upper panel (A–E) shows native 
equine RPE cells. Lower panel (F–J) shows cultured equine RPE cells of passage-4. 
Native cells show positive immunoreactivity for CRALBP (B) and RPE65 (C). Native 
cells show no immunoreactivity for fibronectin (D) and CD49c (E). In passage-4 RPE 
cells, CRALBP (G) and RPE65 (H) do not show immunoreactivity, other than fibronectin 
(I) and CD49c (J), which is found positive in passage-4 cells. Nuclei were stained with  
4'6-diamidino-2-phenylindole (DAPI). A and F show Nomarski imaging of the respective 
RPE cells, native (A) and passage-4 (F). 
 
By immunocytochemistry, a cytoplasmatic punctuate expression pattern could be shown for 
CRALBP, whereas RPE65 showed positive immunoreactivity throughout the cytoplasm and parts of 
the membrane in native RPE cells. Fibronectin and CD49c were present in passage-4 RPE cells and 
absent in native cells, which could be shown by immunoblotting and immunocytochemistry  
Int. J. Mol. Sci. 2012, 13 14061 
 
(Figures 3 and 4). Immunocytochemistry of passage-4 cells showed a perinuclear staining for 
fibronectin and a punctuate staining for CD49c. On mRNA level, a distinct signal in passage-4 RPE 
cells and only a faint signal in native cells for fibronectin and CD49c could be demonstrated.  
Beta-actin was abundant in both states, native and passage-4 (Figures 2 and 3). 
3. Discussion 
The RPE forms the outer blood-retinal barrier and plays an essential role in visual function [18]. 
Since it is located between the choroids and the neurosensory retina, it has to fulfill important 
functions, like absorption of light, reisomerization of all-trans retinal into 11-cis retinal, protection 
against photooxidation, epithelial transport of ions, nutrients and fluids, phagocytosis of photoreceptor 
outer segments, secretion of essential factors for the integrity of neighboring tissues and supporting the 
immune privilege of the inner eye [19]. As one characteristic of ERU is the breakdown of the outer 
blood-retinal barrier, our aim is to elucidate the pathomechanisms that are involved in this breakdown. 
Therefore, performing functional studies on equine RPE cells will be necessary to understand their role 
in ERU [20]. We set our focus on cell surface membrane proteins in this study, as we expect them to 
be targets for initiating events in the breakdown of the outer blood-retinal barrier in eyes of ERU 
diseased horses. In order to detect differentially regulated cell surface membrane proteins in the eyes 
of affected horses, it is a prerequisite to identify the cell surface membrane proteome of equine RPE 
cells in the physiological state. We compared native equine RPE cells with passage-4 cells to 
determine if there were any changes in this proteome due to cultivation and dedifferentiation. Changes 
in the whole proteome without specific focus on cell surface membrane proteins in cultured human 
RPE cells compared to native human RPE cells were described previously [14]. To our knowledge, we 
are the first to describe the cell surface membrane proteome of native and cultured equine RPE.  
A total of 112 proteins were identified by LC MS/MS, of which 84% were cell membrane proteins 
(Table 1). Twenty-three proteins were concurrently expressed in both, native and passage-4 RPE cells 
which equals 20.5% of all 112 identified proteins (Table 1, proteins 1–23). Whereas 28 proteins (25% 
of all 112 identified proteins) were exclusively expressed in native cells (Table 1, proteins 24–51),  
61 proteins (54.5% of all 112 identified proteins) were expressed only in passage-4 cells (Table 1, 
proteins 52–112), indicating a profound re-organization of the cell surface proteome in cultured equine 
RPE cells.  
As expected, beta-actin, an ubiquitously expressed housekeeping protein [21], was equally 
expressed in both examined states (Table 1, protein 3). Among the equally expressed proteins,  
six cytokeratins were present, which are intermediate filament proteins (Table 1, proteins 7–12). 
Desmoplakin, a desmosomal protein which mediates intercellular adhesion in human RPE cells [22], 
was also equally expressed in both states of equine RPE cells (Table 1, protein 13), as well as basigin 
(Table 1, protein 2), which plays a key role in extracellular matrix (ECM), remodeling [23] and 
neuroplastin (Table 1, protein 18), which belongs to the same protein family [24]. Basigin was already 
described as being expressed by human RPE in situ and by a human RPE cell line, namely  
ARPE-19 [25]. Further, four different types of Na+/K+ ATPases were identified, which are usually 
localized apically in RPE cells [26]. Three of them were expressed in both states (Table 1,  
proteins 15–17), whereas one of them was only present in passage-4 RPE cells (Table 1, protein 98). 
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Among the 28 proteins exclusively expressed in native equine RPE cells, there were three 
cytokeratins (Table 1, proteins 31–33) and few ion-channel proteins, namely Kir7.1; solute carrier 
family 1, member 4; solute carrier family 12, member 2; solute carrier family 13, member 3; solute 
carrier family 16, member 1; solute carrier family 4, member 7; solute carrier family 6, members 6, 9, 
13, 20; and solute carrier organic anion transporter family, member 1A2 and member 1B3 (Table 1, 
proteins 39–49). Further, we identified two RPE cell markers, CRALBP and RPE65 [16] (Table 1, 
proteins 29 and 38). CRALBP, RPE65 and also RDH5, which was exclusively expressed by native 
RPE cells (Table 1, protein 37), are proteins playing a key role in the visual cycle [27–29]. CRALBP, 
RPE65 and RDH5 were abundant in native and absent in cultured RPE cells. Correlating with our 
results, former research observed that RPE65 and CRALBP, both proteins associated with highly 
specialized functions of the RPE, were absent in cultured RPE cells [14,30]. Regarding that CRALBP 
is not only expressed by RPE cells, but also, for instance, by Mueller glial cells [31], we believe that 
RPE65 is an excellent marker for the verification of native in comparison to cultured RPE, as it was 
found to be differentially expressed by Western blot analysis, immunocytochemistry and even PCR 
(Figure 2–4). Another reason for considering RPE65 an attractive protein for further research in ERU 
is the fact that immunoreactions against RPE65, next to CRALBP and S-Antigen, are known to induce 
experimental autoimmune uveitis in rats [7,32,33]. 
Besides cell surface proteins, which were only expressed by native equine RPE cells (Table 1, 
proteins 23–51), there were 61 proteins exclusively detected in cultured passage-4 RPE cells (Table 1, 
proteins 52–112). Interestingly, there was a notable increased expression of several clusters of 
differentiation (CD) molecules in passage-4 cells (Table 1, proteins 59–79) compared to the native 
state, whereas ion channel protein expression decreased (Table 1). An altered expression  
of ECM proteins could be observed as well, for instance of fibulin 1, fibulin 2, fibronectin and 
thrombospondin 1. (Table 1, proteins 85–87 and 108). Thrombospondin 1 is not only an ECM protein 
expressed by RPE cells, but it is also known to suppress activated T-cells [34], which additionally 
makes this protein very interesting for ERU research. It was found to be exclusively expressed in 
cultured equine RPE cells. Fibronectin was also absent in native equine RPE cells, but abundant in 
passage-4 cells (Table 1, protein 85; Figures 3 and 4). Immunocytochemically, fibronectin shows 
positive immunoreactivity with a perinuclear expression pattern in passage-4 cells, and no 
immunoreactivity was observed in native RPE cells (Figure 4). In vivo, the RPE basement membrane 
contains ECM proteins such as laminin, fibronectin, vitronectin and collagen type VI [35]. When RPE 
is dissociated from the eyecup, the RPE basement membrane remains in the eyecup, and there is no 
matrix for the RPE cells to attach to in vitro. In order to adhere and form a monolayer of epithelial 
cells in vitro, RPE cells begin to produce ECM proteins, such as fibronectin, themselves [36,37]. The 
perinuclear expression pattern in passage-4 indicates an augmented protein synthesis of the ECM 
protein fibronectin in passage-4 cells. Furthermore, there was an altered expression of proteins 
associated with cell adhesion, predominantly integrins (Table 1, proteins 69–72, 76 and 92–95), that 
are known to not only interact with ECM proteins [38], but also cadherins, catenin, cell adhesion 
molecule 1, dystroglycan 1, vitronectin and versican (Table 1, proteins 55, 56, 58, 73, 80, 81 and 112). 
CD49c, which is also known as integrin-alpha 3, belongs to a family of receptors for ECM and  
cell adhesion molecules [39]. Gullapalli et al. observed an increased expression of CD49c on 
transcriptomic and proteomic level in cultured human RPE cells [40], whereas uncultured human RPE 
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cells did not express or only expressed low amounts of CD49c. These findings were consistent with 
their real-time PCR results [40]. We were able to demonstrate an altered expression in passage-4 cells 
as well, compared to native cells on mRNA and proteomic level (Table 1, protein 70; Figures 2–4). In 
Western blot analysis, no signal in the lane with native RPE cell lysate was detectable, whereas the 
lane with passage-4 cell lysate showed a distinct signal. Also, no staining for CD49c could be shown in 
native cells by immunocytochemistry, confirming CD49c expression on proteomic level to be specific 
for passaged RPE cells (Figures 2–4). 
Interestingly, we showed that the cell surface proteome of equine RPE cells shifted from proteins 
with RPE specialized functions (CRALBP, RPE65 and RDH5) in native cells (Table 1, proteins 29, 37 
and 38; Figures 2–4) to proteins that are associated with cell adhesion and ECM formation (integrins, 
cell adhesion molecule 1, catenin, thrombospondin 1, fibronectin) in cultured cells (Table 1, proteins 
58, 80, 85, 108 and 93–95; Figures 2–4). 
The altered expression of molecules that are associated with cell adhesion in passage-4 cells could 
be clearly demonstrated in Figure 1 (dark green segments). According to Figure 1A, in native equine 
RPE cells, only 2.29% of all respective proteins are associated with cell adhesion (dark green segment), 
whereas in passage-4 cells, 12.06% of the expressed proteins are capable of cell adhesion as their 
biological process (Figure 1B, dark green segment). These observations in equine cells correspond to 
the findings in cultured human cells where a shift to processes such as cell adhesion could be 
accordingly displayed [14]. Another notable increase in passage-4 RPE cells could be seen in cell 
communication (Figure 1A,B, grey segments). As the normal function of the RPE depends on the 
maintenance of tight adhesions between the cells [41], and cell-cell adhesion and intercellular 
communication are integrated [42], it is not surprising that this biological process alters concurrently in 
passage-4 RPE cells (Figure 1A,B, grey segments). Interestingly the relation between cell adhesion 
and communication remains equal in both states (Figure 1A,B, grey segments). 
In contrast to alteration of proteins associated with cell adhesion and communication in passage-4 
cells, Figure 1 demonstrates a noticeable decrease of proteins that are associated with transport as their 
biological process in passage-4 cells (6.74%) (Figure 1B, bright blue segment) compared to the native 
state (34.86%) (Figure 1A, bright blue segment), correlating with the observations in Table 1, where in 
passage-4 cells a strong decrease in ion transporting channels was noted. 
Our results therefore clearly demonstrate that there is a profound re-organization of the cell surface 
membrane proteome in cultured equine RPE cells compared to native RPE cells. We believe that one 
reason for these differences is most probably the in vitro situation, which profoundly differs from the 
situation in vivo, where RPE is provided with environmental specific factors by surrounding tissue that 
are not included in standard cell culture media [43]. The lack of the choroid on the basal side and the 
retina on the apical side of the cells in culture could lead to a decrease of functions like transport, 
which is not needed in its entirety in vitro. Then again, other functions, as cell-adhesion, become more 
important. Since retinal tissue is destroyed and retinal architecture is widely disintegrated in ERU [13], 
we assume that the proteomic changes in diseased eyes are very similar to the changes observed in this 
study, as disintegrated and destroyed retinae could be compared to a missing retina in culture. In some 
ways, culture is like a disease state, where a degenerate neural retina no longer sends RPE the signals 
that modulate key functions [11]. Another reason for the differences in cell surface proteomes of native 
and cultured RPE cells is that RPE cells do not divide in vivo, in contrast to RPE cells in vitro [44]. All 
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of this may lead to an altered expression of proteins, as the proteome is dynamic and changes with the 
physiological state of the cell [14]. In the past, changes in protein expression due to in vitro culturing 
and passaging, could be observed in cells other than RPE cells as well [45,46]. Our results clearly 
validated this and demonstrated that, by culturing equine RPE cells, changes in the cell surface 
proteome occur and that the passage-4 cells only to a limited extend show properties of native 
physiological RPE cells. 
Regarding the short time post mortem until further processing of the equine eyes used in this study 
in comparison to eyes obtained from human donors, we were able to perform analyses on native RPE 
cells without loss of proteins due to degradation. By means of biotinylation and LC MS/MS in order to 
capture, enrich and identify cell surface membrane proteins, we were the first to characterize the cell 
surface proteome of RPE cells of two different states, native and passage-4. Detecting a total of 28 CD 
molecules, we contributed to a profile and repertoire of RPE CD antigens of which, to our knowledge, 
ten have not yet been described to be expressed in RPE cells of any species before (Table 1,  
proteins 25–27, 59, 60 and 64–67). We believe that a cell surface proteome of healthy equine RPE 
cells is essential and a necessity in order to compare RPE cells of healthy physiological and diseased 
pathological state in the future, and thus provides the basis for further research in this field. 
Furthermore, knowledge of the cell surface proteome of equine RPE cells is not only of great value for 
research of ERU, but also of major importance for research in the human field of other severe eye 
diseases with participation of the RPE as ocular tissue, namely Age Related Macular Degeneration 
(AMD), human autoimmune uveitis and Proliferative Vitreoretinopathy (PVR) [47–49]. Since ERU is 
the only spontaneous model for human autoimmune uveitis [50], it is of great importance to investigate 
and understand the pathomechanisms leading to this severe disease. The lack of proteins with highly 
specialized RPE functions in cultured RPE compared to native cells requires the use of native cells in 
research. Therefore, we believe that primary cells should be used for experiments in which it is 
important to evaluate changes in these specialized proteins in healthy versus diseased RPE cells. 
Since cultured cells show a great tendency to form intercellular adhesions, these cells could be used 
for functional studies where tight junctional formation is required, for example as transmigration 
assays on semi-permeable filter systems. In regard to availability, cultured cells have a significant 
advantage for the use in research compared to native cells. Further, they can be passaged, and thus 
multiplied, enabling functional studies to be performed with a much higher amount of cells and a 
higher diversity of experimental setups. 
Nevertheless, future proteomic studies on diseased equine RPE cells have to be conducted to clarify 
if the shift of the cell surface proteome in cultured equine RPE cells to proteins, which were not 
detectable in native cells, could be similar to equine RPE cells in diseased state, as was already shown 
for protein expression profile of dedifferentiated human RPE cells and initial stages of PVR [14]. 
To summarize, we were the first to provide a characterization of the cell surface proteome of native 
and cultured equine RPE cells by means of cell surface protein biotinylation and high resolution mass 
spectrometry. Additionally, we showed that there is a considerable difference between native and 
cultured equine RPE cells regarding their cell surface protein expression by investigation of 
differentially expressed proteins. Additionally, we were the first to describe ten CD molecules in 
equine RPE cells, which, to our knowledge, have not yet been described in the context of RPE cells of 
any species (Table 1, proteins 25–27, 59, 60 and 64–67). Cultured RPE cells experience a profound  
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re-organization of the cell surface proteome since only 20.5% of all 112 identified proteins were 
expressed equally in both cell states. An interesting question that arises is how quickly the proteome of 
equine RPE cells changes after preparation of native cells and subsequent cultivating. As we set our 
focus on the comparison between native RPE cells and cells of passage-4, future experiments need to 
be conducted to evaluate if and when this proteomic shift or a tendency is notable in passage-2 and -3 
cells. Nevertheless we believe that we have set a great foundation with regard to future experimental 
studies on the function of RPE cells in physiological and pathological conditions. 
4. Experimental Section 
4.1. Preparation of Equine Retinal Pigment Epithelium Cells 
No experimental animals were used in this study. Eyes providing healthy equine retinal pigment 
epithelium samples were obtained at a local abattoir. Eyes were considered normal based on the 
diagnosis of the veterinarian present at the abattoir, medical histories of the horses as provided by their 
owners and preliminary histological analysis. The collection and use of equine eyes from animals that 
were killed due to a research-unrelated cause, was approved for purposes of scientific research by  
the appropriate board of the veterinary inspection office Munich, Germany (Permit number: 
8.175.10024.1319.3). RPE cells from eyes of eight different eye-healthy horses were used in this 
study, four biological replicates of native cells and four biological replicates of passage-4 cells.  
For each verification procedure, we had at least two technical replicates (two for PCR and 
immunocytology, four in Western blots). 
RPE cells were prepared as follows: First, residual periocular tissue was carefully removed with 
forceps and scissors. Then, the intact eyes were rinsed in 70% Ethanol for 2 min followed by a short 
washing step in cold phosphate buffered saline (PBS). Afterwards, eyes were stored in sterile 
Dulbecco’s Modified Eagle Medium (DMEM) until further processing. All following preparation steps 
were performed under a laminar flow hood with sterile instruments. Eye globes were cut open 
circumferentially, and anterior parts of the eye, vitreous and neurosensory retina, were carefully 
removed. Posterior eyecups were rinsed twice with 37 °C pre-warmed PBS to wash clear of residual 
vitreous and retinal tissue without destroying the RPE layer. For complete removal of retinal tissue, 
especially the rod outer segments, eyecups were filled with pre-warmed 1mM PBS/EDTA pH 7.4 and 
incubated at room temperature (RT) for 15 min. The PBS/EDTA solution was discarded and, in order 
to enzymatically detach the RPE cell layer, eyecups were filled with pre-warmed dissociation buffer 
containing 1 µL papain (CellSystems, Troisdorf, Germany) per milliliter buffer (1 mM PBS/EDTA  
pH 7.4, 260 mM L-Cysteine, Sigma Aldrich, Deisenhofen, Germany, 1% BSA, AppliChem, 
Darmstadt, Germany). The eyecups were incubated at 37 °C and 5% CO2 atmosphere for 25 min. 
Then, the RPE cells were resuspended in dissociation buffer within the eyecup. The enzymatic activity 
of papain was blocked by transferring the suspension containing the RPE cells into DMEM 
supplemented with 10% heat-inactivated fetal calf serum (FCS) and 1% penicilline/streptomycine 
(P/S). The cell suspension was centrifuged at RT, 130× g for 5 min, and the resulting cell pellet was 
carefully washed twice with pre-warmed PBS. Finally, the RPE cells were either seeded into T25 cell 
culture flasks (Sarstedt, Nümbrecht, Germany), or biotinylated and processed for mass spectrometry. 
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For passage-4 cells, RPE cells were cultured in DMEM supplemented with 10% heat-inactivated FCS 
and 1% P/S. The cells were maintained at 37 °C and 5% CO2 atmosphere until they reached confluence 
after 14 days of cultivation. For protein expression analysis by mass spectrometry, cells were harvested 
with Trypsin/EDTA (Biochrom, Berlin, Germany), washed twice with cold PBS and centrifuged in 
between washing steps at 4 °C, 500× g for 10 min. Prior to cell lysis, cell surface membrane proteins 
of 1.6 × 106 passage-4 RPE cells and 5.0 × 105 native RPE cells were labeled with 542 µg biotin and 
50 µg biotin, respectively. After 30 min rotation at 4 °C and two centrifugation steps at 2800× g and 
16,000× g for 10 min each at 4 °C, cells were lysed with 1% Nonidet P-40, 150 mM NaCl, 1 × Roche 
Complete Protease Inhibitor, EDTA-free; 5 mM 2-Iodacetamide in 10 mM Tris-HCl pH 7.6 and 
biotinylated cell surface proteins were captured using Streptavidin-beads (IBA, Goettingen, Germany). 
After extensive washing to remove non-specifically bound proteins, captured proteins were cleaved 
through digesting beads overnight with trypsin (Promega, Mannheim, Germany) followed by 
incubation with glycerol-free PNGase F (New England Biolabs, Frankfurt/Main, Germany) at 37 °C. 
Finally, peptides were analyzed by LC-MS/MS. 
4.2. Mass Spectrometry 
LC-MS/MS mass spectrometry was performed as previously described [1,5]. Briefly, cell lysates 
were subjected to on-membrane trypsin digest. Resulting peptides were separated on a reversed phase 
chromatography column (PepMap, 15 cm × 75 µm ID, 3 µm/100A pore size, LC Packings), which was 
operated on a nano-HPLC apparatus (Ultimate 3000, Dionex, Idstein, Germany) connected to a linear 
quadrupole ion-trap Orbitrap (LTQ Orbitrap XL, Thermo Fisher Scientific, Schwerte, Germany). The 
mass spectrometer was operated in the data-dependent mode to automatically switch between 
Orbitrap-MS and LTQ-MS/MS acquisition. Survey full scan MS spectra (from m/z 300 to 1500) were 
acquired in the Orbitrap resolution R = 60,000 at m/z 400. The method used allowed parallel selection 
of up to the ten most intense ions for fragmentation on the linear ion trap using collision induced 
dissociation at a target value of 100,000 ions and subsequent dynamic exclusion for 30 s. MS/MS 
spectra were exported from the Progenesis software as Mascot Generic file (mgf) and used for  
peptide identification with Mascot (version 2.3.02, Matrix Science: London, UK; available online: 
http://www.matrixscience.com, accessed on 26 June 2012) in the Ensembl database for horse (Equus 
caballus; EquCab2.56.pep, available online: ftp://ftp.ensembl.org/pub/current_fasta/equus_caballus/pep/, 
accessed on 26 June 2012) containing a total of 22641 protein sequences. A protein was considered as 
identified if the confidence score was higher than 30 at a significance threshold for the Mascot result of 
p ≤ 0.01. 
4.3. Gene Ontology (GO) 
Gene Ontology annotations were retrieved from Ensembl and EMBL-EBI QuickGO database. GO 
annotations were available for all identified proteins and were classified based on three organizing 
principles of GO, namely: biological process, cellular component and molecular function. GO 
annotations for each protein were hierarchically summarized using AmiGO. Based on these 
summarized GO annotations pie charts were made, illustrating differences in biological processes, 
cellular component and molecular function between native and passage-4 equine RPE cells. In this 
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manuscript pie charts representing differences in biological processes of native and passage-4 RPE 
cells are presented. Biological processes, which are represented by 1.1% or less of all proteins, are 
summarized in the field “others” (Figure 1A,B). 
4.4. Polymerase Chain Reaction (PCR) 
RNA was isolated from freshly isolated equine RPE and cultured RPE of passage-4 using RNeasy 
Mini Kit (Qiagen, Hilden, Germany) according to the manufacturer’s protocol. Using RevertAid First 
Strand cDNA Synthesis Kit (Thermo Scientific, Schwerte, Germany), 2 µg of RNA were reverse 
transcribed in presence and absence of reverse transcriptase, according to the manufacturer’s protocol. 
PCR was then performed in a total volume of 50 µL using the cDNA as a template in the presence of 
specific primers for the respective proteins. Reaction buffer, dNTPs and Taq DNA Polymerase were 
obtained from Fermentas (St. Leon-Rot, Germany). The thermocycler, which was used for PCR, was a 
Tetrad PTC-225 Thermal Cycler (MJ research, St. Bruno (Quebec), Canada). PCR, which was 
performed on samples that were reverse transcribed to cDNA in the absence of reverse transcriptase, 
did not show any amplified product. Amplified products were separated by 2% agarose gel 
electrophoresis, stained with Serva DNA Stain G (Serva Electrophoresis GmbH, Heidelberg, 
Germany) and visualized with UV illumination (Herolab UVT-40M, Wiesloch, Germany) (Figure 2). 
4.5. Western Blot Analysis 
Retinal pigment epithelial cell pellets were solubilized in lysis buffer (9 M urea, 2 M thiourea,  
1% DTT, 4% CHAPS, and 2.5 mM each of EGTA and EDTA), and protein content was quantified 
with Bradford assay (Sigma-Aldrich, Deisenhofen, Germany). Equal total protein amounts (5 µg) of 
RPE samples were resolved in 1D SDS gels and then blotted semidry onto polyvinyl-difluoride 
membranes (GE Healthcare, Freiburg, Germany). Unspecific binding was blocked with 5% non-fat dry 
milk in PBS with 0.05% Tween20 (PBS-T) and 5% goat serum. Blots were incubated with primary 
antibodies overnight at 4 °C. For verification, we used the following primary antibodies: mouse  
anti-human beta-actin (Sigma-Aldrich, Deisenhofen, Germany; dilution: 1:7000), rabbit anti-human 
RPE65 (Santa Cruz, Heidelberg, Germany; dilution: 1:800), anti-equine CRALBP antiserum  
(self-made; dilution: 1:1000) [7]), rat anti-human CD49c (Ascenion, München, Germany; reported  
cross-reactivity to horse, dilution: 1:500) and rabbit anti-human Fibronectin (Thermo Scientific, 
Schwerte, Germany; dilution: 1:1000). After washing, blots were incubated with respective 
peroxidase-coupled (POD) secondary antibodies (goat anti-rat IgG POD, Sigma-Aldrich, Deisenhofen, 
Germany; dilution: 1:3000; goat anti-rabbit IgG POD, Sigma-Aldrich, Deisenhofen, Germany; 
dilution: 1:3000; goat anti-mouse IgG POD, Sigma-Aldrich, Deisenhofen, Germany, dilution: 1:5000; 
and goat anti-horse IgG Fc-POD, Biozol, Eching, Germany; dilution: 1:10000). Signals were detected 
by enhanced chemoluminescence (ECL) on X-ray films (Christiansen, Planegg, Germany). Protein 
expression was quantified after imaging the signals on a transmission scanner using LabScan 5.0 
software (GE Healthcare, Freiburg, Germany, 2003) and densitometric analysis with ImageQuantTL 
software (GE Healthcare, Freiburg, Germany, 2003). Signals were normalized to beta-actin content 
after staining of lanes with monoclonal mouse anti-beta-actin antibody (Sigma-Aldrich, Deisenhofen, 
Germany; dilution: 1:7000) prior to statistical analysis. As Kolmogorov-Smirnov test showed that data 
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were not distributed normally (p ≤ 0.05). Mann-Whitney test was applied for calculation of statistical 
significance (p ≤ 0.05). Statistical analysis was performed using Paleontological Statistics software 
(PAST, available online: http://folk.uio.no/ohammer/past/index.html, accessed on 3 July 2012). 
4.6. Immunocytochemistry 
For immunocytochemistry, native equine RPE cells were set onto glass slides immediately after 
obtaining these cells from equine eye globes. Equine RPE cells of passage-4 were trypsinized in order 
to detach them from the cell culture flask and then set onto glass slides. Glass slides were then fixed in 
ice cold acetone for 10 min, followed by blocking with 1% BSA in PBS-T and 5% normal goat serum 
for 40 min at RT to prevent unspecific antibody binding. For fluorescence labeling, slides were 
incubated overnight at 4 °C with the following primary antibodies: mouse anti-human CRALBP (Santa 
Cruz, Heidelberg, Germany; dilution: 1:50), rabbit anti-human RPE65 (Santa Cruz, Heidelberg, 
Germany; dilution: 1:200), rabbit anti-human Fibronectin (Thermo Scientific, Schwerte, Germany; 
dilution: 1:500) and rat anti-human CD49c (Ascenion, München, Germany; reported cross-reactivity  
to horse; dilution: 1:200). Glass slides were then incubated with secondary antibodies for 30 min at  
RT (Alexa Fluor 546 goat anti-mouse, Alexa Fluor 546 goat anti-rabbit, Alexa Fluor 546 goat  
anti-rat; Invitrogen, Karlsruhe, Germany; dilution: 1:500). Cell nuclei were counter-stained with  
4',6 Diamidino-2-phenylindole (DAPI; Invitrogen, Karlsruhe, Germany; dilution: 1:1000). Finally, 
glass slides were mounted with glass cover slips using Dako fluorescent mounting medium  
(Dako, Hamburg, Germany). Fluorescent images were recorded using Axio Imager M1 or Z1  
(Zeiss, Göttingen, Germany) and Axio Vision 4.6 software (Zeiss, Göttingen, Germany). 
5. Conclusions 
The results of this study indicate a profound re-organization of the cell surface proteome of 
passage-4 equine RPE cells compared to native cells. We provided the first proteome profile of cell 
surface proteins of native and cultured equine RPE cells by means of biotinylation and LC MS/MS. 
We believe that our findings are a prerequisite and of great value, not only in future ERU research, but 
also in research of other ocular diseases with participation of the RPE, for example AMD, human 
autoimmune uveitis or PVR. In our future studies, we will consider the differences in protein 
expression of native and cultured RPE cells, thus enhancing the transferability of in vitro studies to the 
actual pathomechanisms in vivo. 
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